141 related articles for article (PubMed ID: 17680883)
21. Neurons from substantia nigra increase the efficacy and potency of second messenger arising from striatal astroglia dopamine receptor.
Hansson E; Rönnbäck L
Glia; 1988; 1(6):393-7. PubMed ID: 2906631
[TBL] [Abstract][Full Text] [Related]
22. [Effect of electroacupuncture scalp point-through-point therapy on the expression of tyrosine hydroxylase and dopamine transporter mRNAs in substantia nigra of Parkinson's disease model rats].
Wang S; Qi XJ; Han D
Zhongguo Zhen Jiu; 2009 May; 29(5):391-4. PubMed ID: 19489498
[TBL] [Abstract][Full Text] [Related]
23. Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO) mice.
Küppers E; Krust A; Chambon P; Beyer C
Psychoneuroendocrinology; 2008 Jul; 33(6):832-8. PubMed ID: 18472350
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in dopamine- and vesicular monoamine-transporter functions.
Dluzen DE; McDermott JL
Ann N Y Acad Sci; 2008 Oct; 1139():140-50. PubMed ID: 18991858
[TBL] [Abstract][Full Text] [Related]
25. Oestrogen regulates mitochondrial respiratory chain enzyme transcription in the mouse spinal cord.
Johann S; Dahm M; Kipp M; Beyer C; Arnold S
J Neuroendocrinol; 2010 Aug; 22(8):926-35. PubMed ID: 20403091
[TBL] [Abstract][Full Text] [Related]
26. Single administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline increases the extracellular concentration of dopamine in rat striatum.
Katagiri N; Abe K; Kitabatake M; Utsunomiya I; Horiguchi Y; Hoshi K; Taguchi K
Neuroscience; 2009 Jun; 160(4):820-8. PubMed ID: 19285542
[TBL] [Abstract][Full Text] [Related]
27. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
[TBL] [Abstract][Full Text] [Related]
28. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
Liu B; Dluzen DE
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
[TBL] [Abstract][Full Text] [Related]
29. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
30. Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells.
Wang J; Michelhaugh SK; Bannon MJ
Eur J Neurosci; 2007 Apr; 25(7):1982-6. PubMed ID: 17439486
[TBL] [Abstract][Full Text] [Related]
31. Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats.
Lin CH; Huang JY; Ching CH; Chuang JI
J Pineal Res; 2008 Mar; 44(2):205-13. PubMed ID: 18289173
[TBL] [Abstract][Full Text] [Related]
32. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
[TBL] [Abstract][Full Text] [Related]
33. Bak Foong protects dopaminergic neurons against MPTP-induced neurotoxicity by its anti-apoptotic activity.
Liu B; Xie JX; Tsang LL; Rowlands DK; Ho LS; Gou YL; Chung YW; Chan HC
Cell Biol Int; 2008 Jan; 32(1):86-92. PubMed ID: 17920944
[TBL] [Abstract][Full Text] [Related]
34. Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner.
Pifl C; Wolf A; Rebernik P; Reither H; Berger ML
Neuropharmacology; 2009 Feb; 56(2):531-40. PubMed ID: 19000913
[TBL] [Abstract][Full Text] [Related]
35. Aging effects on the dopamine transporter expression and compensatory mechanisms.
Cruz-Muros I; Afonso-Oramas D; Abreu P; Pérez-Delgado MM; Rodríguez M; González-Hernández T
Neurobiol Aging; 2009 Jun; 30(6):973-86. PubMed ID: 17976862
[TBL] [Abstract][Full Text] [Related]
36. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
[TBL] [Abstract][Full Text] [Related]
37. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
Lavoute C; Weiss M; Rostain JC
Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
[TBL] [Abstract][Full Text] [Related]
38. Selective regulation of growth factor expression in cultured cortical astrocytes by neuro-pathological toxins.
Braun A; Dang J; Johann S; Beyer C; Kipp M
Neurochem Int; 2009 Dec; 55(7):610-8. PubMed ID: 19524632
[TBL] [Abstract][Full Text] [Related]
39. Kinetic Properties and Pharmacological Modulation of High- and Low-Affinity Dopamine Transport in Striatal Astrocytes of Adult Rats.
Sočan V; Dolinar K; Kržan M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791173
[TBL] [Abstract][Full Text] [Related]
40. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
